Trevi Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Business Update
Interim Analysis in Phase 2 CANAL Trial Showed Primary Efficacy Endpoint of Cough Reduction in Idiopathic Pulmonary Fibrosis was Highly Statistica...
Source: businessinsider.com